Overview

Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides

Status:
Completed

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to test the effect and safety of three different doses of ABT-143 compared to simvastatin in subjects with elevated levels of low density lipoprotein cholesterol ("bad cholesterol") and triglycerides.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca

Treatments:

Simvastatin